Article Information
History
- February 13, 2021.
Article Versions
- Version 1 (July 21, 2020 - 03:00).
- Version 2 (July 22, 2020 - 10:48).
- Version 3 (September 11, 2020 - 00:48).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Andrew T. Hale1,2,
- Dan Zhou2,
- Rebecca L. Sale2,
- Lisa Bastarache3,
- Liuyang Wang4,5,
- Sandra S. Zinkel6,
- Steven J. Schiff7,
- Dennis C. Ko4 and
- Eric R. Gamazon2,8,9,10,*
- 1Vanderbilt University School of Medicine, Medical Scientist Training Program, Nashville, TN
- 2Vanderbilt Genetics Institute & Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN
- 3Department of Bioinformatics, Vanderbilt University School of Medicine, Nashville, TN
- 4Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC
- 5Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, NC
- 6Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
- 7Centers for Neural Engineering and Infectious Disease Dynamics, Departments of Neurosurgery, Engineering Science and Mechanics, and Physics, Penn State University. University Park, PA
- 8Clare Hall, University of Cambridge, Cambridge, UK
- 9MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
- ↵*Correspondence and requests for materials should be addressed to E.R.G. (eric.gamazon{at}vanderbilt.edu)
Posted February 13, 2021.
The genetic architecture of human infectious diseases and pathogen-induced cellular phenotypes
